Skip to content
OpenCapital
Get started

Johnson & Johnson JNJ Innovative Medicine — Additions to Property, Plant & Equipment

Other segment segments

MEDTECH
$509M+6.0%
General Corporate
$32M-17.9%
Consumer Health
$0-100%

Similar metrics at other companies

Abbott logo
ABTMedical Devices — Additions to Property and Equipment
$147M-5.8%
Williams Companies logo
WMBProperty, Plant and Equipment, Additions
$1.04B+48.5%
Celanese Corporation logo
CEEngineered Materials — Additions
$7M-53.3%
Abbott logo
ABTEstablished Pharmaceuticals — Additions to Property and Equipment
$20M-39.4%
Oceaneering International logo
OIIManufactured Products — Property, Plant and Equipment, Additions
$1.57M-35.1%
American Assets Trust logo
AATProperty, plant, and equipment additions
$23.24M+34.9%

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$623.71B+66.9%
Enterprise value$657.01B+61.9%
P/E29.6×+13.2×
P/S6.5×+2.3×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's innovative medicine — additions to property, plant & equipment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's innovative medicine — additions to property, plant & equipment?
Johnson & Johnson (JNJ) reported innovative medicine — additions to property, plant & equipment of $508M in Q1 2026.
How has Johnson & Johnson's innovative medicine — additions to property, plant & equipment changed year-over-year?
Johnson & Johnson's innovative medicine — additions to property, plant & equipment increased by 84.1% year-over-year, from $276M to $508M.
What is the long-term trend for Johnson & Johnson's innovative medicine — additions to property, plant & equipment?
Over 4 years (2021 to 2025), Johnson & Johnson's innovative medicine — additions to property, plant & equipment has grown at a 14.7% compound annual growth rate (CAGR), from $1.2B to $2.08B.
What does innovative medicine — additions to property, plant & equipment mean?
This metric tracks the capital expenditures made to acquire or improve physical assets, such as manufacturing facilities and laboratories, within the Innovative Medicine segment. It reflects the level of investment in the infrastructure required to support production and research.